PEPTIDE RESEARCH SERIES 29
ARA-290 (10MG)
Erythropoietin-Derived Peptide | 11 Amino Acids
PEPTIDE INFORMATION
| Name | ARA-290 (10MG) |
|---|---|
| Classification | Synthetic Peptide |
| Length | 11 Amino Acids |
| Origin | Erythropoietin Helix B Domain |
| Research Areas | Innate Repair Receptor Signalling, Inflammatory Pathways, Neural Tissue Models, Wound Repair |
ARA-290 (Cibinetide) is an 11-amino-acid peptide derived from helix B of the erythropoietin molecule. Preclinical research examines its selective interaction with the innate repair receptor, modulation of inflammatory signalling, and cellular repair pathways in tissue and neural models. Supplied as a lyophilised powder in a 3 mL vial.
RESEARCH FOCUS AREAS:
- Innate repair receptor signalling studies
- Inflammatory and cytokine pathway research
- Peripheral nerve and tissue repair models
ARA-290 (10MG) Amino Acid Sequence
Gln-Glu-Gln-Leu-Glu-Arg-Ala-Leu-Asn-Ser-Ser
Certificate of Analysis
Every Imperial Peptides product is accompanied by a Certificate of Analysis (COA) confirming identity, purity (≥99%), and potency. Our COA documentation is generated by accredited third-party laboratories.